You are currently viewing the summary.
See the full text- Join / Subscribe
- Buy article
- member account Enable
- Renew subscription
- Recommend a subscription to your library
- Help for librarians
Summary
the Ebola epidemic in West Africa has caused enormous suffering, but scientists also see it as a chance to test experimental therapies that could save lives in the future. With the decreasing number of cases, however, it becomes less likely that all tests will reach a conclusion. Now scientists are wondering whether some tests must be stopped so that the most promising therapies tests that only now available have a better chance to reach a conclusion. A group of experts from the World Health Organization gave zmapp TKM-Ebola and the highest priority, but in a recent meeting did not call for ongoing studies of favipiravir and convalescent blood arrest. The experts convince a group of Italian doctors to test zmapp instead of amiodarone heart drugs and criticized an interferon test has now begun in Guinea.
0 Komentar